Cargando…
Correction: Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522840/ https://www.ncbi.nlm.nih.gov/pubmed/34676057 http://dx.doi.org/10.18632/oncotarget.28096 |
| _version_ | 1784585167456698368 |
|---|---|
| author | Sugase, Takahito Takahashi, Tsuyoshi Serada, Satoshi Fujimoto, Minoru Ohkawara, Tomoharu Hiramatsu, Kosuke Koh, Masahiro Saito, Yurina Tanaka, Koji Miyazaki, Yasuhiro Makino, Tomoki Kurokawa, Yukinori Yamasaki, Makoto Nakajima, Kiyokazu Hanazaki, Kazuhiro Mori, Masaki Doki, Yuichiro Naka, Tetsuji |
| author_facet | Sugase, Takahito Takahashi, Tsuyoshi Serada, Satoshi Fujimoto, Minoru Ohkawara, Tomoharu Hiramatsu, Kosuke Koh, Masahiro Saito, Yurina Tanaka, Koji Miyazaki, Yasuhiro Makino, Tomoki Kurokawa, Yukinori Yamasaki, Makoto Nakajima, Kiyokazu Hanazaki, Kazuhiro Mori, Masaki Doki, Yuichiro Naka, Tetsuji |
| author_sort | Sugase, Takahito |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8522840 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85228402021-10-20 Correction: Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer Sugase, Takahito Takahashi, Tsuyoshi Serada, Satoshi Fujimoto, Minoru Ohkawara, Tomoharu Hiramatsu, Kosuke Koh, Masahiro Saito, Yurina Tanaka, Koji Miyazaki, Yasuhiro Makino, Tomoki Kurokawa, Yukinori Yamasaki, Makoto Nakajima, Kiyokazu Hanazaki, Kazuhiro Mori, Masaki Doki, Yuichiro Naka, Tetsuji Oncotarget Correction Impact Journals LLC 2021-10-12 /pmc/articles/PMC8522840/ /pubmed/34676057 http://dx.doi.org/10.18632/oncotarget.28096 Text en Copyright: © 2021 Sugase et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Correction Sugase, Takahito Takahashi, Tsuyoshi Serada, Satoshi Fujimoto, Minoru Ohkawara, Tomoharu Hiramatsu, Kosuke Koh, Masahiro Saito, Yurina Tanaka, Koji Miyazaki, Yasuhiro Makino, Tomoki Kurokawa, Yukinori Yamasaki, Makoto Nakajima, Kiyokazu Hanazaki, Kazuhiro Mori, Masaki Doki, Yuichiro Naka, Tetsuji Correction: Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer |
| title | Correction: Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer |
| title_full | Correction: Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer |
| title_fullStr | Correction: Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer |
| title_full_unstemmed | Correction: Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer |
| title_short | Correction: Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer |
| title_sort | correction: lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522840/ https://www.ncbi.nlm.nih.gov/pubmed/34676057 http://dx.doi.org/10.18632/oncotarget.28096 |
| work_keys_str_mv | AT sugasetakahito correctionlipolysisstimulatedlipoproteinreceptoroverexpressionisanovelpredictorofpoorclinicalprognosisandapotentialtherapeutictargetingastriccancer AT takahashitsuyoshi correctionlipolysisstimulatedlipoproteinreceptoroverexpressionisanovelpredictorofpoorclinicalprognosisandapotentialtherapeutictargetingastriccancer AT seradasatoshi correctionlipolysisstimulatedlipoproteinreceptoroverexpressionisanovelpredictorofpoorclinicalprognosisandapotentialtherapeutictargetingastriccancer AT fujimotominoru correctionlipolysisstimulatedlipoproteinreceptoroverexpressionisanovelpredictorofpoorclinicalprognosisandapotentialtherapeutictargetingastriccancer AT ohkawaratomoharu correctionlipolysisstimulatedlipoproteinreceptoroverexpressionisanovelpredictorofpoorclinicalprognosisandapotentialtherapeutictargetingastriccancer AT hiramatsukosuke correctionlipolysisstimulatedlipoproteinreceptoroverexpressionisanovelpredictorofpoorclinicalprognosisandapotentialtherapeutictargetingastriccancer AT kohmasahiro correctionlipolysisstimulatedlipoproteinreceptoroverexpressionisanovelpredictorofpoorclinicalprognosisandapotentialtherapeutictargetingastriccancer AT saitoyurina correctionlipolysisstimulatedlipoproteinreceptoroverexpressionisanovelpredictorofpoorclinicalprognosisandapotentialtherapeutictargetingastriccancer AT tanakakoji correctionlipolysisstimulatedlipoproteinreceptoroverexpressionisanovelpredictorofpoorclinicalprognosisandapotentialtherapeutictargetingastriccancer AT miyazakiyasuhiro correctionlipolysisstimulatedlipoproteinreceptoroverexpressionisanovelpredictorofpoorclinicalprognosisandapotentialtherapeutictargetingastriccancer AT makinotomoki correctionlipolysisstimulatedlipoproteinreceptoroverexpressionisanovelpredictorofpoorclinicalprognosisandapotentialtherapeutictargetingastriccancer AT kurokawayukinori correctionlipolysisstimulatedlipoproteinreceptoroverexpressionisanovelpredictorofpoorclinicalprognosisandapotentialtherapeutictargetingastriccancer AT yamasakimakoto correctionlipolysisstimulatedlipoproteinreceptoroverexpressionisanovelpredictorofpoorclinicalprognosisandapotentialtherapeutictargetingastriccancer AT nakajimakiyokazu correctionlipolysisstimulatedlipoproteinreceptoroverexpressionisanovelpredictorofpoorclinicalprognosisandapotentialtherapeutictargetingastriccancer AT hanazakikazuhiro correctionlipolysisstimulatedlipoproteinreceptoroverexpressionisanovelpredictorofpoorclinicalprognosisandapotentialtherapeutictargetingastriccancer AT morimasaki correctionlipolysisstimulatedlipoproteinreceptoroverexpressionisanovelpredictorofpoorclinicalprognosisandapotentialtherapeutictargetingastriccancer AT dokiyuichiro correctionlipolysisstimulatedlipoproteinreceptoroverexpressionisanovelpredictorofpoorclinicalprognosisandapotentialtherapeutictargetingastriccancer AT nakatetsuji correctionlipolysisstimulatedlipoproteinreceptoroverexpressionisanovelpredictorofpoorclinicalprognosisandapotentialtherapeutictargetingastriccancer |